Vomifoliol is a plant-derived compound likely serving as the immediate precursor of dehydrovomifoliol due to its metabolic conversion from abscisic acid. Vomifoliol, in conjunction with Stigmasterol, exhibits antiproliferative activity on human lung cancer cell lines, making Vomifoliol relevant in studies of plant metabolite biotransformation and anticancer bioactivity.
